June 2009 Issue of MMM
You know that CME is in a bit of trouble when its longest-serving provider is hanging up its accreditation credentials and stepping out of the ...
Pharmaceutical marketers and their clients are facing formidable challenges in devising their global marketing strategies in 2009. A sluggish worldwide economy, patent expirations and generic ...
The policies stemming from DC will be important in determining what pharma products and medical devices are accepted and successful and which do not meet ...
Clashes often occur between the creative and analytic departments when the time comes to run tests that confirm which ideas best achieve a promotional objective. ...
Joe Dysart reports on the best internet tools for preventing a reputation meltdown
Is the hourly-rate model used by the majority of pharmaceutical marketers and advertisers antiquated? Mike Myers provides some alternatives to the current system including the ...
Heading up the biggest brand in online health has its benefits. "When I tell people I work at WebMD, they smile and tell me how ...
Pay for performance is not a new concept between health plan payers and providers, but very recently new risk/performance-based agreements between pharmas and payers have ...
A few weeks ago I brought some samples of the anti-viral drug Tamiflu (oseltamivir) to a TV studio to use as a prop on a ...
Drug and device companies are still digesting DDMAC's 14 untitled letters issued in March declaring sponsored links on search engines for 45 drugs to be ...
Health Strategies Group, a provider of market intelligence to the pharmaceutical and biotechnology industries, has realigned its pharmaceutical sales force effectiveness service under a more ...
Featuring news about Impact Rx, Wikipedia, Manhattan Research and SDI
Cegedim Dendrite has announced the expansion of its Alliance Program at the eyeforpharma Sales Force Effectiveness Europe 2009 Conference in Barcelona, Spain.
Med Ed Report
Featuring news about the Coalition for Healthcare Communication, the Center for Medicine in the Public Interest, the AMA and Covisint
The Institute of Medicine (IOM) has called for the development of "a new system of funding accredited CME...free of industry influence" and ordered "a consensus ...
The National Alliance on Mental Illness posted a web registry of individual grants and contributions from corporate contributors and foundations.
Quadrant HealthCom Inc. (QHI) announced a partnership with The Doctor's Channel to provide select video reviews of articles on two QHI titles: Cutis and The ...
Elsevier came under fire for a series of deceptive publications published in Australia between 2000 and 2005.
Featuring news about Brandofino Communications, Slack Incorporated, CMPMedica and the New England Journal of Medicine
How will the recent FDA warning letters for pharma-sponsored search engine advertising affect your search engine marketing (SEM)/search engine optimization (SEO) strategy going forward?
USA Today launched a web feature providing consumers with a database of the nation's most influential doctors.
BreastCancer.org has opened the door for banner advertising and tapped online health network HealthCentral for the development of sponsorship programs, according to an announcement.
Featuring news about Answers Media, HealthiNation, US News Media Group and UnitedHealth Group
Consumers who saw display campaigns on Yahoo! for three pharma brands demonstrated a considerable uptick in prescription fills and web traffic to brand sites, according ...
Consumers worldwide overwhelmingly prefer medicines that have been around a long time to the latest treatments, and over half prefer generics to branded drugs given ...
Consumer drug marketers huddled in Washington for the start of the DTC National Conference in mid-April, unsure of the future but certain they faced a ...
Sanofi Pasteur and the March of Dimes have recruited Jennifer Lopez to serve as the face of a whooping cough awareness campaign.
Kudos to Novartis and Deutsch-NYC for their illuminating DTC campaign for Exelon Patch!
Eli Lilly & Co. is taking its Vision Racing Wellness Tour on another lap around the racing circuit, offering fans free diabetes screening.
Featuring news about Boniva, DDMAC and the ED Advertising Decency Act
A federal court in Vermont quashed the efforts of several marketing research firms to overturn a statewide ban that restricts the use of prescriber-identifiable (PI) ...
GfK launched a new product—Flashpoints—allowing marketers to survey 100 physicians in one week.
Featuring news about Cadient Interactive, GlobalHealthPR, AbelsonTaylor and Physician Reach
Yogi Berra had it right when he said, "It ain't over 'til it's over."
The FDA's director of drugs, Janet Woodcock, believes the movement toward comparative effectiveness research will lead to a more internationally harmonized drug development process.
The FDA's drug center is increasing and speeding up its enforcement actions, according to compliance director Deborah Autor.
Don't think of Twitter as your new website. It's not yet a must for all marketing mix models. So how can you tell if you ...
Brand teams have had huge success with traditional DTC advertising. Slowly but surely, new media channels were adopted, but the fundamentals remained the same: reach ...
My friend and former colleague, the late Steve Gross, was having dinner one night with the head of rheumatology from a major teaching hospital. The ...
- Biogen ends Tecfidera DTC campaign, citing prescriptions
- As immuno-oncology therapies evolve, so will the marketing
- GSK Consumer Healthcare to prioritize digital after agency review
- Five things for pharma marketers to know: Thursday, July 21, 2016
- Five things for pharma marketers to know: Tuesday, July 26, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Novartis considers new sales model for experimental cancer therapy
- Sponsored Podcast: No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers
- W2O names Gillespie chief strategy officer of medtech practice
- Five things for pharma marketers to know: Wednesday, July 27, 2016
- DigitasLBi's Carlos Ricque on Why Simple Ads Are the Hardest to Make
- Healthcare marketers: Don't forget about the baby boomers